Topotarget Announces Updates on Belinostat in Two Clinical Trials - NSCLC and Ovarian Cancer - Drugs.com MedNews
Links shared publicly online about this topic.
- 440total visits
Topotarget Announces Updates on Belinostat in Two Clinical Trials - NSCLC and Ovarian Cancer - Drugs.com MedNews
Copenhagen, Denmark - 14 March, 2011 - Today Topotarget A S (NASDAQ OMX TOPO.CO) announced updates on belinostat in two clinical trials - NSCLC and ovarian canc
View full resource at drugs.com
Tags: Cancer, Non-Small Cell Lung Cancer, Ovarian Cancer, Drug, Clinical Trial, Women's Health
Most Recently Shared on March 14, 2011 at 5:02 pm By:
Topotarget Announces Updates on Belinostat in Two Clinical Trials - NSCLC and Ovarian Cancer: Copenhagen, ... http://bit.ly/fLW9VD #drug
Advertisement
